CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
![GlobeNewswire](../../../Content/images/providers/GN.png)
CARGO Therapeutics, Inc. (CRGX)
Company Research
Source: GlobeNewswire
– Appointment adds strategic finance and broad operating experience to Board as Company advances potentially pivotal Phase 2 clinical study for CAR T-cell therapy candidate, firicabtagene autoleucel (firi-cel) – SAN CARLOS, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced the appointment of Jane Pritchett Henderson to its Board of Directors. Ms. Henderson will also serve as a member of the audit and compensation committees. “Jane’s appointment exemplifies CARGO’s ongoing commitment to strong corporate governance, deep industry expertise, and diverse, independent thought, given her decades of healthcare investment banking experience in addition to her extensive operating and executive leadership experience across numerous biotech companies,” said Gina Chapman, President and Chief Executive Office
Show less
Read more
Impact Snapshot
Event Time:
CRGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRGX alerts
High impacting CARGO Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CRGX
News
- CARGO Therapeutics, Inc. (NASDAQ: CRGX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $37.00 price target on the stock.MarketBeat
- CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director [Yahoo! Finance]Yahoo! Finance
- CARGO Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- CARGO Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
- CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing [Yahoo! Finance]Yahoo! Finance
CRGX
Earnings
- 3/21/24 - Beat
CRGX
Sec Filings
- 6/28/24 - Form EFFECT
- 6/27/24 - Form 424B3
- 6/17/24 - Form S-1
- CRGX's page on the SEC website